ARTICLE
Auteur(s) : Felicidade
Trindade1, Teresa Fiadeiro2, Antonio
Torrelo3, Hans Christian Hennies4,
Ingrid Hausser5, Heiko Traupe6
1Department of Dermatology, Hospital de Cascais,
Av. Brigadeiro Victor Novais Gonçalves, 2755-009 Cascais,
Portugal
2Department of Dermatology, Hospital da Luz,
Lisbon, Portugal
3Department of Dermatology, Hospital Infantil
Universitario Niño Jesús, Madrid, Spain.
4Cologne Center for Genomics, Division
of Dermatogenetics, University of Cologne, Germany
5Department of Dermatology, University
of Heidelberg, Germany
6Department of Dermatology, University
of Muenster, Germany
accepté le 18 F�vrier 2010
Bathing suit ichthyosis (BSI) is a rare and unique clinical form
of autosomal recessive congenital ichthyosis [1]. It is
characterized by dark-grey or brownish scaling restricted to the
“bathing suit” areas, whereas the extremities and central face are
almost completely spared. Recently, it has been demonstrated to be
a temperature-sensitive phenotype, which is caused by specific
transglutaminase-1 (TGase-1) gene mutations leading to protein
dysfunction in higher temperature conditions [2].
Case report
A 2-year-old girl from Guinea presented with lamellar scaling
affecting her trunk, scalp and neck. She was the second child of
non-consanguineous parents, and there was no history of ichthyosis
in the family, including her 8-year-old brother. She had been born
with a collodion membrane encasing the whole body, which was
gradually replaced by large, dark scales restricted to the bathing
suit areas. The extremities as well as the central face and
suprarenal lumbar areas were almost completely spared (figures 1A).
Histopathological study showed hyperkeratosis and a normal granular
layer (figure 2).
Ultrastructural analyses were performed on the affected and
unaffected skin. Affected skin revealed groups of single polygonal
clefts representing remnants of cholesterol crystals within the
thickened massive horny layer (figure 3A). The
unaffected skin of the arm showed a normal ultrastructure and a
normal diameter of the stratum corneum (figure 3B).
We performed a biochemical in situ test for the TGase-1 enzyme
activity: cryosections of 3-4 μm were blocked with 1% bovine serum
albumin in phosphate-buffered saline for 30 min and directly
incubated with 0.1 mM TGase substrate biotinyl cadaverine
(Molecular Probes, Leiden, The Netherlands), which is incorporated
into the cornified cell envelope in the presence of calcium ions
(5 mM). At physiological pH 7.4 (100 mM Tris-HCl) this
reaction is almost exclusively performed by TGase-1 (reaction time
90 min). Incubation with 5 mM EDTA served as negative
control. The incorporated biotinylated substrate was incubated with
fluorochrome-coupled streptavidin 1:100 (Jackson ImmunoResearch
Laboratoires Inc., West Grove, PA, USA).
In affected skin there was a complete lack of the normal
pericellular TGase-1 signal in the stratum granulosum (figure 4A), while
some non-specific TGase activity could be noted in the stratum
corneum. In contrast, there was a normal pattern of TGase-1
activity in unaffected skin (figure 4B).
EDTA blood was collected from the patient. DNA was extracted
from peripheral blood leukocytes using standard procedures. The
translated exons 2-15 of TGase-1 gene (TGM1) were amplified by
polymerase chain reaction. A homozygous mutation was
identified in exon 6 of the TGase-1 gene (TGM1). The mutation
at nucleotide c.944 converts an arginine residue to leucine,
designated as p.R315L [3].
The patient was treated with emollients, and by the
age of 4 years she developed scaling on the elbow
fossae and popliteal areas.
Discussion
Bathing suit ichthyosis (BSI) is a rare phenotypic variant of
autosomal recessive lamellar ichthyosis [1, 4]. Patients are born
as collodion babies with ectropion. During the
first weeks of life, after shedding of the collodion membrane,
a very characteristic distribution of scaling develops, involving
the trunk, neck and scalp but sparing the suprarenal lumbar area,
the center of the face and extremities [1]. In some patients a
distinct scaling is also detected on the elbow fossae and popliteal
spaces [2]. There are no associated extracutaneous abnormalities in
BSI.
BSI was initially described in South African patients [1], but
has also been reported in Caucasian individuals from Europe and the
Mediterranean area (Germany, Netherlands, France, Turkey and
Morocco) [2] totalizing 18 patients in the literature. Two
patients had a history of consanguinity. Moreover, all
8 patients from South Africa had the same mutation, p.R315L,
pointing to a founder effect in this group of patients. Seven of
these belong to the Nguni ethnic groups (Zulu, Swazi, and Xhosa)
[5]. Interestingly, our patient showed the same homozygous
mutation, but she was from Guinea and did not belong to any of
these ethnic groups.
Loss or drastic reduction of TGase-1 function leads to defective
cornified cell envelope formation and collapse of the stratum
corneum lipid barrier [6]. TGase-1 activity was shown to be
differentially present in unaffected and affected skin in BSI. In
unaffected skin TGase1 shows a normal in situ activity and affected
skin reveals a residual cytoplasmic enzyme activity (table 1). Furthermore, comparing the
ultrastructural features of affected and unaffected skin, the
cholesterol clefts associated with TGase-1 deficiency were seen in
affected skin but not in normal skin (table 1) [2].
Sequencing analyses in BSI patients have revealed homozygous or
compound heterozygous TGM1 mutations in 14 cases reported so
far (table 1) [2, 5]. In African
individuals from South Africa as well as in our patient from Guinea
the same mutation was detected in exon 6 of TGM1, a homozygous
G>T transversion at nucleotide c.944, thus suggesting a founder
effect. Oji et al. suggested that skin temperature might play
a role for the development of BSI. Digital thermography showed a
striking correlation between warmer body areas and the presence of
scaling [2]. Aufenvenne et al. compared the TGase-1 activity
of 8 BSI cases with 3 cases of generalized lamellar ichthyosis
and showed that BSI mutations exhibit a decreased enzyme activity
and a marked shift in temperature optimum from 37 °C for
normal (“wild type”) TGase-1 to 31 °C (BSI-mutation TGase-1),
explaining the clinical phenotype with the unaffected areas on
the central face, arms and legs having a lower body
temperature [7].
Table 1 Summary of the BSI cases reported
in the literature
|
N°
|
Age/Sex
|
Origin/Race
|
Mutation
|
Exon
|
Effect
|
in vivo Tgase-1 Act.
|
Ultracstructure
|
Reference
|
|
1
|
14y/F
|
Turkey/Caucasian
|
Homozygous, c.826T>A
|
5
|
Tyr265Asn
|
Unaffected Skin-↓ Affected skin-abnornal
|
Unaffected Skin-N Affected skin-Choresterol clefts
|
Oji et al.
|
|
2
|
35y/F
|
Netherlands/Caucasian
|
c.376C>T, c.425G>A
|
3, 3
|
Arg126Cys, Arg142His
|
Unaffected Skin-↓ Affected skin-abnornal
|
n.d.
|
Oji et al.
|
|
3
|
2y/M
|
Germany/Caucasian
|
c.790C>T, c.877-2A>G
|
5
|
Arg264Trp
|
n.d.
|
n.d.
|
Oji et al.
|
|
4
|
5y/M
|
Germany/Caucasian
|
c.919C>G, c.1166G>C
|
6, 6
|
Splice-site mutation, Arg307Gly
|
Unaffected Skin-↓ Affected skin-abnornal
|
Collodion skin (1st week)-Choresterol clefts
|
Oji et al.
|
|
5
|
1y/F
|
Germany/Caucasian
|
c.877-2A>G, c.919C>G
|
7, 6
|
Arg389Pro, Splice-site mutation
|
Unaffected Skin-↓ Affected skin-abnornal
|
Collodion skin (1st week)-Choresterol clefts
|
Oji et al.
|
|
6
|
1y/F
|
Morocco/Caucasian
|
c.791G>A, c.1074delC
|
6, 5
|
Arg307Gly, Arg264Gln
|
n.d.
|
Collodion skin (1st week)-Choresterol clefts
|
Oji et al.
|
|
7
|
3y/F
|
Germany/Caucasian
|
Homozygous,c.2060G>A
|
7, 13
|
Ser358fsX26, Arg687His
|
Unaffected Skin-↓ Affected skin-abnornal
|
n.d.
|
Oji et al.
|
|
8
|
16y/M
|
Germany/Caucasian
|
c.877-2A>G, c.943C>T
|
6
|
Splice-site mutation, Arg315Cys
|
Unaffected Skin-↓ Affected skin-abnornal
|
n.d.
|
Oji et al.
|
|
9
|
5y/F
|
France/Caucasian
|
c.788G>A, c.919C>G
|
5, 6
|
Trp263X, Arg307Gly
|
Unaffected Skin-↓ Affected skin-abnornal
|
n.d.
|
Oji et al.
|
|
10
|
16y/M
|
Morocco/Caucasian
|
Homozygous, c.944G>A
|
6
|
Arg315His
|
Unaffected Skin-↓ Affected skin-abnornal
|
n.d.
|
Oji et al.
|
|
11 to 18
|
7-27y/3M, 5F
|
South Africa/Black
|
Homozygous c.944G>T
|
6
|
Arg315Leu
|
n.d.
|
n.d.
|
Arita et al.
|
|
Our case
|
2y/F
|
Guinea/Black
|
Homozygous c.944G>T
|
6
|
Arg315Leu
|
Unaffected Skin-↓ Affected skin-abnornal
|
Unaffected Skin-N Affected skin-Choresterol clefts
|
Current report
|
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Jacyk WK. Bathing-suit ichthyosis. A peculiar phenotype
of lamellar ichthyosis in South African blacks. Eur J Dermatol
2005; 15: 433-6.
2 Oji V, Hautier JM, Ahvazi B, et al.
Bathing suit ichthyosis is caused by transglutaminase -1
deficiency: evidence for a temperature-sensitive phenotype. Hum Mol
Genet 2006; 15: 3083-97.
3 Tok J, Garzon MC, Cserhalmi-Friedman P,
Lam HM, Spitz JL, Christiano AM. Identification of
mutations in the transglutaminase 1 gene in lamellar
ichthyosis. Exp Dermatol 1999; 8: 128-33.
4 Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and
classification of inherited ichthyoses: Results of the First
Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol
2010; in press.
5 Arita K, Jacyk WK, Wessagowit V, et al.
The South African “bathing suit ichthyosis” is a form of lamellar
ichthyosis caused by a homozygous missense mutation, p.R315L, in
transglutaminase 1. J Invest Dermatol 2007; 127: 490-3.
6 Elias PM, Schmuth M, Uchida Y, et al. Basis for abnormal
desquamation and permeability in lamellar ichthyosis. Exp Dermatol
2002; 11: 248-56
7 Aufenvenne K, Oji V, Walker T, et al.
Transglutaminase-1 and Bathing Suit Ichthyosis: Molecular Analysis
of Gene/Environment Interactions. J Invest Dermatol 2009; 129:
2068-71.
|